The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 08, 2019
Filed:
Jul. 02, 2013
Applicant:
S-target Therapeutics Gmbh, Vienna, AT;
Inventor:
Geert Mudde, Breitenfurt, AT;
Assignee:
S-TARGET THERAPEUTICS GMBH, Vienna, AT;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 39/36 (2006.01); A61K 39/35 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 39/001 (2013.01); A61K 39/0003 (2013.01); A61K 39/0005 (2013.01); A61K 39/0008 (2013.01); A61K 39/0011 (2013.01); A61K 39/35 (2013.01); A61K 39/36 (2013.01); A61K 2039/505 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/577 (2013.01); A61K 2039/6031 (2013.01); A61K 2039/64 (2013.01);
Abstract
An immune-regulatory vaccine comprising—a directed adjuvant comprising at least an anti-CD32 moiety linked to a TLR9 ligand and a first peptidic alpha-helix, and—an immunogen with at least one epitope and a second peptidic alpha-helix coiled to the first alpha-helix, a kit for preparing the vaccine, and a sensibilizing vaccine comprising at least an anti-CD32 moiety linked to a TLR9 ligand and a peptidic alpha-helix in a pharmaceutical formulation.